#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    SAPHO syndrome Angiosarcoma Retinitis pigmentosa Liposarcoma Post transplant lymphoproliferative disorder Propionic acidaemia Ischaemic stroke Heart disease congenital Infertility male Scedosporium infection B precursor type acute leukaemia Neurodegenerative disorder Nephroblastoma Primary mediastinal large B-cell lymphoma Factor VIII deficiency More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Trials in Disease Glycogen storage disease type V – Treatment Cholangitis sclerosing – Treatment Metachromatic leukodystrophy – Diagnostics Undifferentiated sarcoma – Trials in Disease Pemphigoid – Trials in Disease Gaucher’s disease type I – Life with Disease Hereditary motor and sensory neuropathy – Trials in Disease Systemic sclerosis pulmonary – Trials in Disease Gaucher’s disease type III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levamlodipine Succinate Apadamtase Alfa MB-HUCART19.1 Folic Acid GSK5764227 Minzasolmin Buclizine Hydrochloride Paracetamol Gen1047 AMO959 Fenfluramine Hydrochloride Magnesium Hydroxide Ltx-315 HUPERZINE A ZILEBESIRAN Human Plasma Protein Lavender Oil Ioflupane (123I) Loperamide Seralutinib More therapies…

    Learn about Your Condition

    Lung adenocarcinoma stage IV Essential hypertension Labour pain Chondroplasty Lung neoplasm malignant Gastric cancer Autoimmune hepatitis Rhabdomyosarcoma Retinopathy proliferative Pulmonary hypertension Methylmalonic acidaemia Osteoporosis postmenopausal Ewing's sarcoma metastatic Endometriosis Stress More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Henri Mondor – 1 rue Gustave Eiffel

Hopital Henri Mondor – 1 rue Gustave Eiffel

51 Av Du Mal De Lattre De Tassigny, Creteil, 94000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tumour of ampulla of Vater
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    France

  • Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Ceftazidime Pentahydrate
    • Ciprofloxacin
    • Colistimethate Sodium
    France

  • Study of Dostarlimab for Patients with Advanced or Metastatic Non-Colorectal/Non-Endometrial Cancer with dMMR/MSI, Compared to Standard Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Mitotane
    • Trabectedin
    • Calcium Folinate
    France

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bortezomib
    • Carfilzomib
    • Dexamethasone
    Belgium Croatia Czechia Denmark Finland France +10

  • Study on the Effect of Post-Surgery Chemotherapy with Irinotecan and Drug Combination for Patients with Colorectal Cancer and Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ondansetron
    • Calcium Folinate
    • Calcium Levofolinate
    France

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Ciclosporin
    • Fludarabine
    Belgium France

  • Study on Dostarlimab Immunotherapy for Patients with Localized Gastric Cancer with Deficient Mismatch Repair or High Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Dostarlimab
    France Italy

  • Study on Customized Antibiotic Treatment Duration for Hospitalized Patients with Community-Acquired Pneumonia Using Cefotaxime and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin
    • Cefotaxime
    • Ceftriaxone
    France

  • Study on UCPVax, Atezolizumab, and Bevacizumab for Patients with Unresectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ucp4
    • Atezolizumab
    • Bevacizumab
    France
Previous Page
1 2 3 4 5 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!